IPP Bureau

Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%

By IPP Bureau - August 12, 2021

It’s an AB-rated generic therapeutic version of Durezol

KK Pant is the new NPPA chairman
KK Pant is the new NPPA chairman

By IPP Bureau - August 12, 2021

It plays a pivotal role in monitoring pharmaceutical pricing

Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness

By IPP Bureau - August 12, 2021

A treatment to prevent extreme symptoms and cut hospitalisation

Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread
Research demonstrates Hoth Therapeutics HT-KIT for mast cell cancers reduces size and spread

By IPP Bureau - August 12, 2021

Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm

Global cell expansion market poised for huge growth
Global cell expansion market poised for huge growth

By IPP Bureau - August 12, 2021

Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030

SAB Biotherapeutics nonclinical data indicates SAB-185 neutralizes Delta and Lambda SARS-CoV-2 Variants
SAB Biotherapeutics nonclinical data indicates SAB-185 neutralizes Delta and Lambda SARS-CoV-2 Variants

By IPP Bureau - August 12, 2021

SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial

Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee
Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee

By IPP Bureau - August 12, 2021

The company is eligible for 12 months exclusivity from launch

Low-cost flexible tactile sensors for robotics and biomedical applications developed
Low-cost flexible tactile sensors for robotics and biomedical applications developed

By IPP Bureau - August 12, 2021

The sensors have been tested for their different level of strains like micro and large scale motion monitoring and have potential applications in biomedical devices, skin electronics, and minimally invasive surgery

Natco Pharma PAT at Rs 75 crore for Q1FY22
Natco Pharma PAT at Rs 75 crore for Q1FY22

By IPP Bureau - August 12, 2021

The company has strong product launches both in India and overseas

Hester Biosciences posts PAT of Rs 11.01 cr in Q1FY22
Hester Biosciences posts PAT of Rs 11.01 cr in Q1FY22

By IPP Bureau - August 12, 2021

The sales of vaccines have registered a growth of 41% in Q1 FY22, and the sale of health products have registered a growth of 94% in Q1 FY22.

New CAP guideline improves diagnoses of patients with Monoclonal Gammopathies
New CAP guideline improves diagnoses of patients with Monoclonal Gammopathies

By IPP Bureau - August 11, 2021

The American Association for Clinical Chemistry (AACC); the American Society for Clinical Pathology (ASCP); the American Society of Hematology (ASH); and the International Myeloma Working Group (IMWG), collaborate to develop the guideline

FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer
FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer

By IPP Bureau - August 11, 2021

High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection

Moderna to set up mRNA manufacturing in Canada
Moderna to set up mRNA manufacturing in Canada

By IPP Bureau - August 11, 2021

The collaboration will support Canada with direct access to rapid pandemic response capabilities

Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx
Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx

By IPP Bureau - August 11, 2021

OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.

Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment
Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment

By IPP Bureau - August 11, 2021

The aim is to create new genomics solutions that could combat cancer and advance market access

Latest Stories

Interviews

Packaging